Veracyte (VCYT) EBT Growth (3y) (2015 - 2026)
Veracyte (VCYT) EBT Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -36.31% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 8.36% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -6.75% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 9.91% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 2.67% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 14.73% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -3.23% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 58.91% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -2.56% |
| 10 | Veracyte | 3.91 Bn | 3.65 Bn | 101.16 Mn | 78.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.68% |
| Dec 31, 2025 | 140.45% |
| Sep 30, 2025 | 60.42% |
| Jun 30, 2025 | 28.66% |
| Mar 31, 2025 | 35.97% |
| Dec 31, 2024 | 32.11% |
| Sep 30, 2024 | 45.63% |
| Jun 30, 2024 | 40.96% |
| Mar 31, 2024 | 65.30% |
| Dec 31, 2023 | -55.87% |
| Sep 30, 2023 | -93.27% |
| Jun 30, 2023 | 9.11% |
| Mar 31, 2023 | 11.61% |
| Dec 31, 2022 | 25.56% |
| Sep 30, 2022 | -69.55% |
| Jun 30, 2022 | -42.48% |
| Mar 31, 2022 | -82.75% |
| Dec 31, 2021 | -46.37% |
| Sep 30, 2021 | -47.72% |
| Jun 30, 2021 | -12.83% |